| ALEMTUZUMAB |
Lemtrada® |
sanofi-aventis Australia Pty Ltd |
|
Nov 2018 |
|
| AMINO ACIDS-SYNTHETIC, FORMULA |
Neocate Junior® Vanilla |
Nutricia Australia Pty Limited |
|
Nov 2018 |
|
| APALUTAMIDE |
Erlyand® |
Janssen-Cilag Pty Ltd |
|
Nov 2018 |
|
| BOTULINUM TOXIN TYPE A |
Botox® |
Allergan Australia Pty Ltd |
|
Nov 2018 |
|
| BRENTUXIMAB VEDOTIN |
Adcetris® |
Takeda Pharmaceuticals Australia Pty. Ltd. |
|
Nov 2018 |
|
| BUPRENORPHINE |
Buvidal® |
Camurus Pty Ltd |
|
Nov 2018 |
|
| CARFILZOMIB |
Kyprolis® |
Amgen Australia Pty Limited |
|
Nov 2018 |
|
| CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ C COMPLEX (LOWER LIMB) |
Dysport® |
Ipsen Pty Ltd |
|
Nov 2018 |
|
| CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ C COMPLEX (UPPER LIMB) |
Dysport® |
Ipsen Pty Ltd |
|
Nov 2018 |
|
| CRISABOROLE |
Staquis® |
Pfizer Australia Pty Ltd |
|
Nov 2018 |
|
| DENOSUMAB |
Xgeva® |
Amgen Australia Pty Limited |
|
Nov 2018 |
|
| DURVALUMAB |
Imfinzi® |
AstraZeneca Pty Ltd |
|
Nov 2018 |
|
| ENCORAFENIB AND BINIMETINIB |
|
Pierre Fabre Australia Pty Ltd |
|
Nov 2018 |
|
| ETANERCEPT |
Brenzys® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2018 |
|
| FERRIC CARBOXYMALTOSE |
Ferinject® |
Vifor Pharma Pty Limited |
|
Nov 2018 |
|
| FLUTICASONE PROPRIONATE WITH EFORMOTEROL |
Flutiform® |
Mundipharma Pty Limited |
|
Nov 2018 |
|
| FOLLITROPIN ALFA WITH LUTROPIN ALFA |
Pergoveris® |
Merck Serono Pty Ltd |
|
Nov 2018 |
|
| GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS |
PKU Glytactin® RTD 15 LITE |
Cortex Health Pty Ltd |
|
Nov 2018 |
|
| GLYCOMACROPEPTIDE FORMULA WITH DOCOSAHEXAENOIC ACID WITH LOW PHENYLALANINE |
PKU GMPro® |
Nutricia Australia Pty Limited |
|
Nov 2018 |
|
| HYPROMELLOSE |
- In a Wink Moisturising®
- Genteal®
|
Alcon Laboratories (Australia) Pty Ltd |
|
Nov 2018 |
|
| INACTIVATED QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION) |
Afluria® Quad |
Seqirus (Australia) Pty Ltd |
|
Nov 2018 |
|
| INOTUZUMAB OZOGAMICIN |
Besponsa® |
Pfizer Australia Pty Ltd |
|
Nov 2018 |
|
| INSULIN ASPART |
Fiasp® |
Novo Nordisk Pharmaceuticals Pty. Limited |
|
Nov 2018 |
|
| ISOTRETINOIN |
Oratane® |
Arrow Pharma Pty Ltd |
|
Nov 2018 |
|
| LACOSAMIDE |
Vimpat® |
UCB Australia Proprietary Limited |
|
Nov 2018 |
|
| LENVATINIB |
Lenvima® |
Eisai Australia Pty Ltd |
|
Nov 2018 |
|
| NIVOLUMAB AND IPILIMUMAB |
|
Bristol-Myers Squibb Australia Pty Ltd |
|
Nov 2018 |
|
| OBETICHOLIC ACID |
Ocaliva® |
Emerge Health Pty Ltd |
|
Nov 2018 |
|
| OSIMERTINIB |
Tagrisso® |
AstraZeneca Pty Ltd |
|
Nov 2018 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2018 |
|
| PEMBROLIZUMAB (MELANOMA) |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2018 |
|
| PEMBROLIZUMAB (NSCLC) |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2018 |
|
| PEMBROLIZUMAB (PMBCL) |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2018 |
|
| PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 13-VALENT ADSORBED |
Prevenar 13® |
Pfizer Australia Pty Ltd |
|
Nov 2018 |
|
| PONATINIB |
Iclusig® |
Specialised Therapeutics Australia Pty Ltd |
|
Nov 2018 |
|
| QUADRIVALENT INFLUENZA VACCINES |
- Afluria® Quad
- FluQuadri®
- Fluarix Tetra®
|
- Sanofi Pasteur
- GlaxoSmithKline Australia Pty Ltd
- Seqirus (Australia) Pty Ltd
- Chief Medical Officer
- Department of Health
|
|
Nov 2018 |
|
| REGORAFENIB |
Stivarga® |
Bayer Australia Ltd |
|
Nov 2018 |
|
| RILUZOLE |
Teglutik® |
Seqirus (Australia) Pty Ltd |
|
Nov 2018 |
|
| RIVAROXABAN |
Xarelto® |
Bayer Australia Ltd |
|
Nov 2018 |
|
| ROMOSOZUMAB |
Evenity® |
Amgen Australia Pty Limited |
|
Nov 2018 |
|
| SAFINAMIDE |
Xadago® |
Seqirus (Australia) Pty Ltd |
|
Nov 2018 |
|
| SAPROPTERIN |
Kuvan® |
BioMarin Pharmaceutical Australia Pty Ltd |
|
Nov 2018 |
|
| SARILUMAB |
Kevzara® |
sanofi-aventis Australia Pty Ltd |
|
Nov 2018 |
|
| TESTOSTERONE |
Testavan® |
Ferring Pharmaceuticals Pty Limited |
|
Nov 2018 |
|
| TIOTROPIUM |
Spiriva® Respimat® |
Boehringer Ingelheim Pty Ltd |
|
Nov 2018 |
|
| TOCILIZUMAB |
Actemra® |
Roche Products Pty Ltd |
Giant cell arteritis (GCA) |
Nov 2018 |
|
| TOFACITINIB |
Xeljanz® |
Pfizer Australia Pty Ltd |
|
Nov 2018 |
|
| VARICELLA ZOSTER RECOMBINANT VACCINE |
Shingrix® |
GlaxoSmithKline Australia Pty Ltd |
|
Nov 2018 |
|
| VENETOCLAX |
Venclexta® |
AbbVie Pty Ltd |
|
Nov 2018 |
|